A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 53,507 shares of PLX stock, worth $120,390. This represents 0.03% of its overall portfolio holdings.

Number of Shares
53,507
Previous 47,073 13.67%
Holding current value
$120,390
Previous $48 Million 109.51%
% of portfolio
0.03%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$0.99 - $1.92 $6,369 - $12,353
6,434 Added 13.67%
53,507 $101 Million
Q3 2024

Nov 14, 2024

SELL
$0.9 - $1.17 $18,981 - $24,675
-21,090 Reduced 30.94%
47,073 $48 Million
Q2 2024

Aug 14, 2024

BUY
$1.1 - $1.32 $74,979 - $89,975
68,163 New
68,163 $79.8 Million

Others Institutions Holding PLX

About Protalix BioTherapeutics, Inc.


  • Ticker PLX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,753,400
  • Market Cap $112M
  • Description
  • Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...
More about PLX
Track This Portfolio

Track Point72 Asia (Singapore) Pte. Ltd. Portfolio

Follow Point72 Asia (Singapore) Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.